Philippines FDA approves first ever generic version of Pfizer anti-Covid pill

Philippines FDA approves first ever generic version of Pfizer anti-Covid pill

Manila (Philippines), January 25: The Philippines Food and Drug Administration (FDA) has approved the world’s first generic version of Pfizer’s anti-Coronavirus pill Paxlovid, just days after the original was granted Emergency Use Authorisation (EUA) by the US FDA.

The Philippines FDA has approved the department of health’s application for a compassionate special permit application for the first generic version of Paxlovid that has been launched by Beximco Pharmaceuticals, a leading generic drugmaker from Bangladesh.

Philippines-based Pharmaceutical company Biocare Lifesciences Inc would be the distributor and importer of a generic drug, which would be sold under the brand name Bexovid in the Philippines.

According to Pfizer, the risk of hospitalisation or death is reduced by 89% when Paxlovid is given within three days of the onset of symptoms and by 88% when given within five days of the onset of symptoms. The treatment, a combination of Nirmatrelvir and Ritonavir tablets, is given together twice a day for five days and is recommended for treatment of mild to moderate cases of Covid-19.

Pfizer data also suggests the drug remains effective against the faster-spreading Omicron variant of the Coronavirus, which is driving the latest surge in Covid-19 cases globally.

“The approval by the Philippines FDA will make Bexovid accessible to Covid-19 patients in the country and add another treatment protocol to the existing drugs. We plan to import 20,000 to 30,000 courses of Bexovid initially and expect the supplies to begin in the first week of February. Bexovid is expected to be priced 50-60% cheaper than the original Pfizer drug, making it an affordable option,” said Dileep Tiwari, Managing Director, Biocare Lifesciences, during an interview with CNN.

Bexovid is recommended as an at-home treatment to help reduce the severity of the infection. The drug has the potential to eliminate many hospitalizations, thus helping reduce the strain on the healthcare infrastructure.

“Bexovid is not meant for patients who are hospitalised. Any patient who is Covid-19 positive can buy the drug from hospitals once supplies begin,” said Mr. Tiwari in a CNN interview.

Separately, Bangladesh’s Directorate General of Drug Administration has also granted EUA for Bexovid to treat mild-to-moderate Covid-19 cases in patients aged 12 and above.

dsprime

150 thoughts on “Philippines FDA approves first ever generic version of Pfizer anti-Covid pill

  1. Undeniably believe that which you stated. Your favorite justification appeared to be on the web the easiest thing to be aware of. I say to you, I definitely get annoyed while people think about worries that they just do not know about. You managed to hit the nail upon the top as well as defined out the whole thing without having side-effects , people can take a signal. Will likely be back to get more. Thanks

  2. Good info and straight to the point. I am not sure if this is actually the best place to ask but do you people have any ideea where to get some professional writers? Thank you 🙂

  3. Needed to send you that bit of observation so as to give thanks as before about the pleasant methods you’ve discussed on this page. It was quite particularly open-handed with you giving freely just what many people could possibly have sold for an ebook to help make some money for their own end, most importantly considering the fact that you might have tried it in case you wanted. These basics also worked as the good way to understand that other people have the identical zeal like my very own to know the truth significantly more concerning this issue. I’m sure there are some more pleasant sessions ahead for individuals who scan through your blog post.

  4. I am often to blogging and i really appreciate your content. The article has really peaks my interest. I am going to bookmark your site and keep checking for new information.

  5. Howdy very cool site!! Man .. Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I am satisfied to find a lot of useful information right here in the post, we want work out more techniques on this regard, thanks for sharing. . . . . .

  6. Its such as you learn my thoughts! You appear to understand a lot approximately this, like you wrote the guide in it or something. I believe that you can do with some percent to force the message home a bit, but instead of that, this is magnificent blog. An excellent read. I will certainly be back.

  7. There are certainly a lot of details like that to take into consideration. That may be a nice point to convey up. I provide the thoughts above as basic inspiration but clearly there are questions like the one you convey up the place a very powerful factor shall be working in trustworthy good faith. I don?t know if greatest practices have emerged round issues like that, but I’m sure that your job is clearly recognized as a fair game. Both boys and girls really feel the impact of just a moment’s pleasure, for the rest of their lives.

  8. I just wanted to post a small note so as to thank you for those fabulous steps you are showing at this website. My rather long internet look up has now been paid with professional facts and strategies to talk about with my neighbours. I ‘d assert that we readers actually are very much blessed to live in a remarkable site with very many marvellous professionals with good secrets. I feel quite grateful to have seen your weblog and look forward to tons of more awesome minutes reading here. Thanks a lot once again for all the details.

  9. This is very interesting, You’re a very skilled blogger. I’ve joined your feed and look forward to seeking more of your excellent post. Also, I’ve shared your site in my social networks!

  10. Whats Happening i’m new to this, I stumbled upon this I have discovered It absolutely useful and it has helped me out loads. I am hoping to give a contribution & aid other users like its helped me. Good job.

Leave a Reply

Your email address will not be published.